Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,359,232
-$53,400 QoQ
Shares Held
8,673
-6.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#535
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LCNB CORP holds $15,058,607 across 8 Drug Manufacturers - General names. NVS ranks #6 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
26,283 | $3,377,365 | |
| 2 | JNJ |
Johnson & Johnson
|
12,559 | $3,189,609 | |
| 3 | AMGN |
Amgen Inc
|
6,635 | $2,402,666 | |
| 4 | LLY |
ELI LILLY & Co
|
1,804 | $2,163,771 | |
| 5 | ABBV |
AbbVie Inc.
|
7,943 | $1,998,776 | |
| 6 | NVS |
Novartis AG
This page
|
8,673 | $1,359,232 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,990 | $287,523 | |
| 8 | PFE |
Pfizer Inc
|
11,614 | $279,665 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,359,232 | 8,673 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,412,632 | 9,248 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,269,231 | 9,206 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,183,783 | 9,231 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,127,934 | 9,321 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,047,466 | 9,396 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $931,645 | 9,574 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,101,201 | 9,574 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,096,963 | 10,304 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,045,554 | 10,809 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,149,442 | 11,384 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,177,399 | 11,559 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,205,269 | 11,944 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,064,532 | 11,571 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $1,104,153 | 12,171 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $944,120 | 12,421 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,077,419 | 12,746 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,161,810 | 13,240 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,045,703 | 11,955 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $975,144 | 11,924 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,101,540 | 12,073 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,041,744 | 12,187 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,150,818 | 12,187 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,094,565 | 12,587 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,124,851 | 12,879 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,032,686 | 12,525 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||